Home - Products - Others - Other Targets - Galanin Message Associated Peptide (1-41) amide

Galanin Message Associated Peptide (1-41) amide

CAS No. 132699-74-2

Galanin Message Associated Peptide (1-41) amide( ——— )

Catalog No. M40207 CAS No. 132699-74-2

Galanin message associated peptide (1-41) amide is a peptide hormone.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Galanin Message Associated Peptide (1-41) amide
  • Note
    Research use only, not for human use.
  • Brief Description
    Galanin message associated peptide (1-41) amide is a peptide hormone.
  • Description
    Galanin message associated peptide (1-41) amide is a peptide hormone.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    132699-74-2
  • Formula Weight
    4643.19
  • Molecular Formula
    C206H326N56O64S
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Helmut G Hinghofer-Szalkay, et al. Circulatory galanin levels increase severalfold with intense orthostatic challenge in healthy humans. J Appl Physiol (1985). 2006 Mar;100(3):844-9.?
molnova catalog
related products
  • 3-O-Acetyl-16 alpha-...

    3-O-Acetyl-16 alpha-hydroxytrametenolic acid has inhibitory activities against AAPH-induced hemolysis of red blood cells, it shows a strong inhibitory activity against 12-O-tetradecanoylphorbol-13-acetate-induced inflammation in mice.

  • Isoflupredone

    Isoflupredone (Isoflupredonum) is a synthetic corticosteroid that acts in vivo by binding to glucocorticoid and corticosteroid receptors in animals (such as horses) to inhibit inflammatory cells and inhibit the expression of inflammatory mediators.

  • WDR5-0102

    WDR5-0102 is a compound that inhibits the WDR5-MLL1 interface (K dis = 7 μM, K d = 4 μM), selectively reducing MLL1 HMT activity without affecting the human H3K4 methyltransferase SETD7 or other HMTs, including G9a, EHMT1, SUV39H2, SETD8, PRMT3, and PRMT5.